SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sonus Pharma (SNUS) ? Opinions -- Ignore unavailable to you. Want to Upgrade?


To: coachbobknight who wrote (297)3/3/2000 10:26:00 PM
From: coachbobknight  Respond to of 384
 
float is ony about 4 million and institutions own about 25%...

one of the fidelity funds has over 500,000 shares i believe...

the tone of the press release about the abbott rights renegotiation was very interesting...

the tone at snus hdqrts also seems very upbeat these days...



To: coachbobknight who wrote (297)3/5/2000 12:05:00 PM
From: Brasco One  Read Replies (3) | Respond to of 384
 
How valuable is echogen as a drug delivery agent?

Could this be the real value of sonus?